It’s Time to Buy the Excessive Fear in Nike

It’s Time to Buy the Excessive Fear in Nike

Shares of Nike (NKE) were destroyed.

Over the last few days, it gapped from about $95 to $75.20 a share, where it’s become ridiculously oversold at lows not seen since 2020.

While the company did beat earnings estimates, sales and guidance were soft. Adjusted EPS of $1.01 on $12.6 billion in revenue was reported, as compare to expectation for 84 cents on $12.9 billion in revenue. “Nike’s full-year revenue missed estimates as well. The company reported $51.4 billion in revenue, a hair shy of the $51.6 billion analysts had planned for. Adjusted earnings of $3.95 a share was above the estimates for $3.70 a share,” added Barron’s.

Multiple analysts downgraded the stock with that news.

However, while Nike may now be one of the most hated stocks on the market, it may also be time to buy the excessive fear. Not only is most of the negativity priced into the gap down, but it’s also time to buy the blood in the streets here. Better, while we wait for the recovery, we can collect Nike’s dividend yield of about 2%.

Remember, crises often create opportunities, as we’ve learned from some of the richest investors. Warren Buffett, for example, tells us to be “fearful when others are greedy, and greedy when others are fearful.” Sir John Templeton taught us to buy excessive pessimism.

Even Baron Rothschild once told investors, “The time to buy is when there’s blood in the streets, even if the blood is your own.”

deal of the month

best growth stocks

Alliance

Bundle package – lifetime subscriptions for all products

Categories

Recent posts

Tags

Connect with Us

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.